Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2013
10/29/2013US8568805 Cognitive function
10/29/2013US8568803 Use of anabolic agents, anti-catabolic agents, antioxidant agents and analgesics for protection, treatment and repair of connective tissues in humans and animals
10/29/2013US8568801 Solid oral sensorial products including stain inhibitor
10/29/2013US8568799 Isolation of a dual COX-2 and 5-lipoxygenase inhibitor from acacia
10/29/2013US8568794 Topical and intravaginal microbicidal and antiparasitic compositions comprising quassinoids or quassinoid-containing plant extracts
10/29/2013US8568790 Medicinal compositions containing honey
10/29/2013US8568788 Nanoparticulated anesthetic composition for topic use
10/29/2013US8568782 Gastroresistant pharmaceutical formulations containing rifaximin
10/29/2013US8568779 Method for producing coenzyme Q10 particle
10/29/2013US8568775 Tablet of paracetamol containing an encapsulated flavorant
10/29/2013US8568773 Glycerophospholipids for the improvement of cognitive functions
10/29/2013US8568772 Modified drugs for use in liposomal nanoparticles
10/29/2013US8568771 Use of microvesicles (MVs) derived from stem cells for preparing a medicament for endo/epithellal regeneration of damaged or injured tissues or organs, and related in vitro and in vivo methods
10/29/2013US8568767 Dietary fiber composition
10/29/2013US8568756 Inhibition of quorum sensing-mediated processes in bacteria
10/29/2013US8568753 Delivery system
10/29/2013US8568752 Treatment and composition for achieving skin anti-aging benefits by corneum protease activation
10/29/2013US8568748 Pharmaceutical formulation comprising cyclosporin and use thereof
10/29/2013US8568747 Enalapril compositions
10/29/2013US8568745 Water-soluble drug carrier and process for producing the same
10/29/2013US8568742 Methods and compositions involving immunostimulatory oligodeoxynucleotides
10/29/2013US8568715 Use of beta-1,3 (4)-endoglucanohydrolase, beta-1,3 (4)-glucan, diatomaceous earth, mineral clay and glucomannan to augment immune function
10/29/2013US8568705 Method for preparing branched functionalized polymers using branched polyol cores
10/29/2013US8568704 Dermatological/pharmaceutical compositions comprising benzoyl peroxide, at least one naphthoic acid compound and at least one polyurethane polymer
10/29/2013US8568699 Soft anticholinergic zwitterions
10/29/2013US8568460 Spine distraction implant and method
10/29/2013US8568455 Spine distraction implant and method
10/29/2013US8568454 Spine distraction implant and method
10/29/2013CA2763246C Ketolide compounds having antimicrobial activity
10/29/2013CA2700242C Use of a combination of an opioid agonist and an opioid antagonist for the treatment of crohn's disease and the symptoms associated with crohn's disease
10/29/2013CA2690229C Alkynyl phenyl derivative compounds for treating ophthalmic diseases and disorders
10/29/2013CA2680825C Topical formulations having enhanced bioavailability
10/29/2013CA2678920C A medicament for treating chronic obstructive pulmonary disease
10/29/2013CA2671975C Film-coated preparation having improved stability
10/29/2013CA2636431C Steroidal compounds as steroid sulphatase inhibitors
10/29/2013CA2635691C Combination therapy with parp inhibitors
10/29/2013CA2630441C Therapeutic uses of steroidal compounds
10/29/2013CA2620829C Method of storing nanoparticle formulations
10/29/2013CA2620179C Inhibitors of voltage-gated sodium channels
10/29/2013CA2612260C Apoptosis promoters
10/29/2013CA2606682C 4-phenyl-5-oxo-1,4,5,6,7,8-hexahydroquinoline derivatives as medicaments for the treatment of infertility
10/29/2013CA2606068C Pyrimidylaminobenzamide derivatives for hypereosinophilic syndrome
10/29/2013CA2605473C Process for preparing quetiapine and quetiapine fumarate
10/29/2013CA2603254C New bicyclic angiotensin ii agonists
10/29/2013CA2595519C Methods of using as analgesics 1-benzyl-1-hydroxy-2,3-diamino-propyl amines, 3-benzyl-3-hydroxy-2-amino-propionic acid amides and related compounds
10/29/2013CA2594687C Use of pyrimidylaminobenzamides for the treatment of diseases that respond to modulation of tie-2 kinase activity
10/29/2013CA2593274C Glycine reuptake inhibitors for treating drug and alcohol dependence
10/29/2013CA2589483C Substituted piperazines as cb1 antagonists
10/29/2013CA2582273C Compositions and methods for treating cognitive disorders using serotonin receptor antagonists
10/29/2013CA2581652C Formulations and methods for treatment of inflammatory diseases
10/29/2013CA2563038C Neurologically-active compounds
10/29/2013CA2562965C Nucleoside derivatives and therapeutic use thereof
10/29/2013CA2558615C Azabicyclo-octane inhibitors of iap
10/29/2013CA2546619C Il-23 and its receptor; related reagents and methods
10/29/2013CA2544965C Heat moisture treated starch for the treatment of hypoglycaemia
10/29/2013CA2529268C Pharmaceutical formulations of amyloid inhibiting compounds
10/29/2013CA2466128C Antibodies to cd40
10/29/2013CA2458001C Regulation of immune responses by manipulation of intermediary metabolite levels
10/29/2013CA2435672C Polypeptides capable of binding to cd64 and comprising one or more heterologous t cell epitopes, and their uses
10/29/2013CA2375467C Antisense therapy for hormone-regulated tumors
10/29/2013CA2371794C Human antibiotic proteins
10/24/2013WO2013159095A1 Ror modulators and their uses
10/24/2013WO2013159064A1 Benzothiazol- 6 -yl acetic acid derivatives and their use for treating an hiv infection
10/24/2013WO2013159029A1 Compositions for topical treatment of microbial infections
10/24/2013WO2013159026A1 Deuterated rigosertib
10/24/2013WO2013159006A1 Polymorphs of (s)-1-(4,4,6,6,6-pentadeutero-5-hydroxyhexyl)-3,7-dimethyl-1h-purine-2,6(3h,7h)-dione
10/24/2013WO2013158961A1 Combination of a non-steroidal anti-inflammatory drug with an anti-histaminic drug intended for ophthalmic use
10/24/2013WO2013158952A1 Isoindolone derivatives
10/24/2013WO2013158928A2 Chemosensory receptor ligand-based therapies
10/24/2013WO2013158894A1 Parasiticidal compositions comprising benzimidazole derivatives, methods and uses thereof
10/24/2013WO2013158892A1 Thioredoxin protein inhibitors and uses thereof
10/24/2013WO2013158874A1 Methods of producing anamorelin hydrochloride having controlled chloride content
10/24/2013WO2013158868A1 Methods of treating diabetes and/or promoting survival of pancreatic islets after transplantation
10/24/2013WO2013158846A1 Novel dxr inhibitors for antimicrobial therapy
10/24/2013WO2013158837A1 Methods and compositions for treatment of attention deficit hyperactivity disorder
10/24/2013WO2013158820A1 Compositions and methods for treating viral diseases
10/24/2013WO2013158814A1 Immediate release, abuse deterrent pharmaceutical compositions
10/24/2013WO2013158810A1 Immediate release pharmaceutical compositions with abuse deterrent properties
10/24/2013WO2013158792A1 Compounds having immunomodulator activity
10/24/2013WO2013158746A1 Compositions and methods for inhibiting viral polymerase
10/24/2013WO2013158649A1 Compositions and methods of modulating 15-pgdh activity
10/24/2013WO2013158628A1 Modulation of angiotensin ii peceptors for the prevention and treatment of cerebral malaria
10/24/2013WO2013158616A1 Treatment of medium-chain acyl-coa dehydrogenase deficiency
10/24/2013WO2013158597A1 (2-ureidoacetamido)alkyl derivatives as formyl peptide receptor 2 modulators
10/24/2013WO2013158585A1 Biomarkers for monitoring intervention therapies for diabetes
10/24/2013WO2013158541A1 Method of utilizing azelaic acid esters to modulate communications mediated by biological molecules
10/24/2013WO2013158482A1 Small molecule compounds for targeting inflammatory conditions
10/24/2013WO2013158422A1 Heterocyclic compounds for controlling invertebrate pests
10/24/2013WO2013158373A1 Indolin-2-one derivatives as protein kinase inhibitors
10/24/2013WO2013158367A1 Cyclopropanecarboxylate esters of purine analogues
10/24/2013WO2013158319A1 Formulations and methods for treatment of wounds and inflammatory skin conditions
10/24/2013WO2013158302A1 Derivatives of docosahexaenoylethanolamide and uses thereof
10/24/2013WO2013158262A1 Ring constrained analogs as arginase inhibitors
10/24/2013WO2013158251A1 Fluorinated benzofuran derivatives
10/24/2013WO2013158197A1 Marinopyrrole derivatives as anticancer agents
10/24/2013WO2013158145A1 Methods of therapeutic monitoring of phenylacetic acid prodrugs
10/24/2013WO2013158143A1 Glufosfamide combination therapies for cancer
10/24/2013WO2013158141A1 Poly(acrylate) polymers for in vivo nucleic acid delivery
10/24/2013WO2013158130A1 Mirtazapine as an appetite stimulant for cats
10/24/2013WO2013158121A1 Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
1 ... 515 516 517 518 519 520 521 522 523 524 525 526 527 528 529 530 531 532 533 534 535 ... 7860